Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

February 08, 2000; 54 (3) Articles

Seizure outcome after temporal lobectomy for temporal lobe epilepsy

A Kaplan-Meier survival analysis

N. Foldvary, B. Nashold, E. Mascha, E.A. Thompson, N. Lee, J.O. McNamara, D.V. Lewis, J.S. Luther, A.H. Friedman, R.A. Radtke
First published February 8, 2000, DOI: https://doi.org/10.1212/WNL.54.3.630
N. Foldvary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Nashold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Mascha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.A. Thompson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.O. McNamara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.V. Lewis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.S. Luther
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.H. Friedman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.A. Radtke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Seizure outcome after temporal lobectomy for temporal lobe epilepsy
A Kaplan-Meier survival analysis
N. Foldvary, B. Nashold, E. Mascha, E.A. Thompson, N. Lee, J.O. McNamara, D.V. Lewis, J.S. Luther, A.H. Friedman, R.A. Radtke
Neurology Feb 2000, 54 (3) 630; DOI: 10.1212/WNL.54.3.630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
953

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective: To determine seizure outcome and its predictors in patients with medically refractory temporal lobe epilepsy (TLE) after temporal lobectomy (TL).

Background: TL is the most common surgical procedure performed in adolescents and adults for the treatment of medically refractory TLE. Seizure outcome has been reported extensively during the first few postoperative years, but little is known beyond that time.

Methods: The authors analyzed seizure outcome in 79 patients who underwent TL for epilepsy at the Duke University Medical Center from 1962 through 1984. Patients with less than 2 years of follow-up and degenerative disorders were excluded. Predictors of seizure outcome were analyzed using Kaplan-Meier survival analyses.

Results: The mean follow-up was 14 years (range, 2.1 to 33.6 years). Using Engel’s classification, 65% of patients were class I, 15% were class II, 11% were class III, and 9% were class IV. At least one postoperative seizure occurred in 55% of subjects. The majority of recurrences (86%) took place within 2 years of surgery. Later recurrences tended not to lead to medical intractability. Higher monthly preoperative seizure frequency was associated with poor seizure outcome. A seizure-free state at 2 years was found to be a better predictor of long-term outcome than the 6-, 12-, and 18-month landmarks.

Conclusions: TL provides sustained, long-term benefit in patients with medically refractory TLE. Seizure-free status at 2 years from the time of surgery is predictive of long-term remission.

Temporal lobectomy (TL) has been a recognized treatment for medically refractory temporal lobe epilepsy (TLE) for several decades. The procedure was pioneered by Wilder Penfield and colleagues at the Montreal Neurologic Institute in the 1930s.1 Despite many years of clinical use, most follow-up studies report postoperative seizure outcome only for the first few years after surgery. From 1955 to the present, 19 series in the English literature have reported outcome after TL in patients with at least 1 year of follow-up. The percentage of patients rendered seizure free (SF) ranges from 21 to 78%. The mean duration of follow-up (available in 11 series) is 4.9 years, and the longest mean follow-up is 9 years. As of 1993, temporal lobe resections were performed in 3,579 patients with refractory TLE worldwide.2 Of this group, 67.9% were SF, 24% were improved, and 8.1% were not improved. Comparing seizure outcome between epilepsy centers is complicated by variability in the extent of resection, patient population, outcome classification, and pathology. This study was performed to analyze seizure outcome and its predictors in patients who underwent TL at a single center from 1962 through 1984. In an effort to analyze long-term outcome, patients operated after this time were excluded.

Methods.

Patient population.

Outcomes of 79 consecutive patients who underwent TL for refractory TLE with at least 2 years follow-up from 1962 through 1984 were analyzed. Seventeen patients were excluded due to inadequate follow-up. Patients with degenerative disorders were also excluded. Surgical candidacy was based on clinical history, neurologic examination, and interictal EEG recordings in all patients. Thirty-four patients had habitual seizures recorded with surface EEG (n = 13), depth electrodes (n = 9), or both (n = 12). Patients operated during and after 1980 routinely had video-EEG recordings with scalp electrodes. Risk factors for epilepsy were identified in 60% of patients. These included febrile seizures (27%), head trauma (23%), perinatal injury (13%), and CNS infection (3%). A family history of epilepsy was elicited in 18% of patients. All patients had complex partial seizures (CPS), usually characterized by oral or manual automatisms. Secondary generalized tonic-clonic seizures were present in 61% of patients. Auras were reported by 78% of patients and were characterized by epigastric sensations (33%); psychic phenomena (21%); olfactory, gustatory, or auditory sensations (14%); nonspecific sensations (27%); or involved multiple symptoms (14%). Interictal EEG recordings revealed unilateral anterior or midtemporal epileptiform discharges ipsilateral to the resection (71%); bitemporal, independent epileptiform activity greater on the side of resection (18%); ipsilateral temporal slowing alone (8%); and frontal maximum epileptiform activity (3%). Results of neuropsychological testing, neuroimaging, and intracarotid sodium amytal tests were not reviewed because these procedures were not performed in all patients. Pathology was reported as hippocampal sclerosis (n = 24) and arteriovenous malformation (n = 2). No pathologic diagnosis was made due to tissue fragmentation in 22 patients. Pathology reports were not available in 31 patients.

Surgical technique.

The temporal lobe was exposed through a temporal craniotomy. Electrocorticography was performed in 70 patients. Intraoperative cortical stimulation was performed in 48 patients. The temporal lobe was resected through a transverse cortical incision at a right angle to the long axis of the lobe, extending 6 cm from the temporal tip on the right and 5 cm from the tip on the left. The incision was extended through the ventricle of the temporal horn. In the earlier patients, the amygdala and anterior hippocampus were removed piecemeal. In later operations, the lateral cortical surface was removed separately and the mesial structures were removed together en bloc. After removal of the anterior hippocampus, electrocorticograms were obtained from the exposed hippocampal surface. More posterior resection of the hippocampus was performed if epileptic activity was observed. The majority of resections (84%) were performed by one neurosurgeon (B.N.). The remaining resections were performed by a neurosurgeon who was trained by the first neurosurgeon (A.H., 14%) and a pediatric neurosurgeon (6%).

Seizure outcome.

Outcome was obtained by medical chart review and, when possible, telephone contact with the patient or an immediate family member. Primary outcomes of interest were time to first seizure and time to first year with less than 75% improvement from baseline in number of seizures per year. Seizure outcome during the entire follow-up period was classified using Engel’s classification.2 Engel class I includes subjects who are SF with or without auras, those with generalized seizures after antiepileptic drug (AED) withdrawal, and subjects who are SF for 2 years or more after at least one postoperative seizure. Engel class II includes patients with rare seizures. Class III is considered worthwhile improvement, which we defined as a 75% or greater reduction in seizures. Class IV includes patients with less than 75% seizure reduction. Atypical seizures occurring within 1 month of the time of surgery were not considered. Data were considered absent during years in which patients failed to return for follow-up unless seizure frequency for the missing years was indicated in subsequent chart notes or during telephone conversations. Of the 79 patients, annual seizure data were available for all years of follow-up in 77 patients. In two patients, data were missing for 6 and 8 years during follow-up periods of 21 and 18 years respectively.

Statistical analysis.

Kaplan-Meier survival analysis was performed to obtain estimates and 95% CIs of SF survival and survival from experiencing a year with less than 75% improvement from baseline at various postoperative intervals. Baseline variables, including age at surgery, duration of seizure disorder, gender, side of resection, recorded seizures during routine or prolonged EEG, and monthly CPS frequency, were assessed as potential predictors of each outcome by comparing the survival curves within each variable with a logrank test. For each outcome, landmark analyses were performed by obtaining survival estimates at 5, 7, and 10 years beyond early marks of 6, 12, 18, and 24 months, and stratifying by whether patients were SF (or not) through the landmark. The Kaplan-Meier analysis provides survival estimates that are robust to variations in follow-up duration because patients are included in the estimates of survival to the time they experience the outcome event (first seizure or year with less than 75% improvement) or are lost to follow-up or death if no event had recurred. We assumed that the length of follow-up available for a patient was not related to seizure status or severity but, rather, was a random process. For death related to epilepsy, a patient was considered to have the outcome at time of death if he/she had not relapsed sooner.

Results.

A total of 57% of patients were men. Left temporal resections were performed in 57% of patients. The mean age (±SD) at the time of surgery was 23.9 ± 9 years. The mean duration of epilepsy was 12.9 ± 8.5 years. The average monthly frequency of CPS was 12.4 (range, 1 to 60 months), and was 10 or less CPSs in 53% of patients, 11 to 20 CPSs in 22% of patients, and more than 20 CPSs in 25% of patients. Thirty-eight patients (48%) were taking AEDs at the time of the last follow-up and 28 patients (35%) were not. Information on drug therapy was not available for the remaining patients.

Four patients died during the follow-up period. One patient who had been SF for 29.5 years developed breast carcinoma. Another patient died of a self-inflicted gunshot wound to the head 20 years postoperatively. This patient had experienced a marked improvement in seizure frequency. Another two patients, who experienced no change in seizure frequency, died of causes related to status epilepticus 4 and 12 years postoperatively.

The mean follow-up was 14.0 years (range, 2.1 to 33.6 years). A total of 75% of patients had a minimum follow-up duration of 8.5 years. Ten patients had less than 5 years of follow-up. At the time of last follow-up, seizure outcome using Engel’s classification was class I, 51 (65%); class II, 12 (15%), class III, 9 (11%); and class IV, 7 (9%). Twenty-eight patients (35%) were entirely SF and 8 (10%) had auras only. Forty-three additional patients (55%) experienced at least one recurrent seizure, and 30 of them (38%) experienced multiple seizures. Seizures recurred within 1 month in 19% of patients (8 of 43), by 6 months in 56% of patients (24 of 43), by 12 months in 67% of patients (29 of 43), and by 24 months in 86% of patients (37 of 43). The median time to first seizure was 5 months (mean, 24 months). Six patients experienced a recurrence after 24 months. The latest recurrence took place 300 months postoperatively after AED withdrawal. In two of these six patients, no additional seizures occurred. Another two patients had multiple recurrent seizures but achieved 2- and 5-year remissions, respectively, by the time of last follow-up. Yearly seizures occurred in the last two patients—one who relapsed after a closed head injury and another after a family death.

Kaplan-Meier survival analyses of time to first postoperative seizure were performed for the group overall and for early landmarks (figure 1). SF survival at 5, 7, and 10 years beyond the 12- and 24-month postoperative landmarks stratified by SF status at the landmark is shown in table 1. As an example, at 10 years past the landmark, an estimated 84% of subjects who were SF at 24 months remained so, versus 71% for subjects SF at the 12-month landmark. The likelihood of remaining SF 5 to 10 years beyond a given early landmark increased with each 6-month increment of seizure freedom from 6 to 24 months postoperatively (not shown).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Kaplan-Meier estimates of postoperative seizure-free (SF) survival by early landmark. The median (50%) SF survival time was 8 years. The percentage of patients still SF at 5 and 10 years after surgery was 52% and 45%, respectively.

View this table:
  • View inline
  • View popup
Table 1.

Early status as indicator of seizure-free (SF) survival

Kaplan-Meier survival estimates for time to first year with less than 75% improvement in seizures are summarized in table 2. By 10 years after surgery, 85% of patients had not experienced such a year. Only 12 patients experienced a year with less than 75% improvement during follow-up. In 10 of these patients, the first year with less than 75% improvement occurred within 4 years of surgery.

View this table:
  • View inline
  • View popup
Table 2.

Early status as indicator of < 75% improvement survival

Age at surgery, duration of seizure disorder, gender, side of resection, recorded seizures during routine or prolonged EEG, and monthly CPS frequency were analyzed as predictors of seizure outcome. As shown in figure 2, preoperative monthly CPS frequency of less than 20 was associated with a higher likelihood of seizure freedom (p = 0.009, logrank test). SF estimates of 72%, 67%, 56%, and 50% at 6 months and 1, 5, and 10 years were observed in subjects with less than 20 seizures per month compared with 50%, 44%, 28%, and 17% for patients with more than 20 seizures per month. The other baseline variables were not predictive of time to relapse or time to a year with less than 75% improvement. Specifically, patients with recorded seizures during routine or prolonged EEG (n = 37) had similar seizure outcome to those who did not (n = 42, p = 0.73).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Kaplan-Meier analysis of preoperative seizure frequency in quartiles of data. Seizure frequency was divided in 1 to 5, 6 to 10, 11 to 20, and more than 20 seizures per month. Patients with more than 20 seizures per month were significantly less likely to be seizure free (SF) than the rest of patients (p = 0.009).

Discussion.

This series demonstrates the sustained, long-term benefit of TL for the treatment of medically refractory TLE. Mean follow-up after TL is 14 years—to our knowledge the longest reported in the literature. An improvement in seizures of 75% or more was obtained in 91% of patients. At least one seizure recurred in 55% of patients. These data are comparable with a more recent series in which 55% of patients were SF or had only experienced auras after TL, 20% had rare seizures or more than an 80% seizure reduction, and 45% experienced at least one recurrent seizure during a 5-year follow-up period.3 An SF state was achieved in 80% of patients after TL for epilepsy due to temporal lobe tumors and vascular lesions with a median follow-up of 6 years.4 Similar to prior reports, we found that the percentage of patients SF at any given year remained relatively stable.3,5 In our series, patients with more than 20 seizures per month were significantly less likely to become SF than those with less frequent seizures. This finding has not been reported previously.

In an attempt to study outcome in patients with the longest possible follow-up, we chose to include patients who had surgery at least 10 years before data collection (1984), realizing that duration of follow-up would be shorter in some patients. During 1984, there was a change of staff in the epilepsy center that included the surgeon who performed the majority of procedures. Subsequently, fewer patients had long-term follow-up documented adequately. Also, at this time, the size of the TL evolved to a more limited lateral resection (3 cm) and a more aggressive resection of the hippocampus independent of electrocorticographic findings. For these reasons, we excluded patients operated after 1984. The decision to include patients with a minimum of 2 years follow-up was based on previous literature in which seizure outcome 2 years after surgery was found to be predictive of long-term outcome. Follow-up of less than 5 years was present in only 10 patients in the current series. We chose not to exclude these patients because the Kaplan–Meier analysis takes into account the variability in follow-up times. This method uses all available follow-up information for each patient and is geared particularly toward studies with differing lengths of follow-up.

Our data support the use of the 2-year landmark as the best predictor of subsequent seizure outcome after TL. Patients who were SF at 2 years had a 94% chance of still being SF at 5 years, 87% at 7 years, and 84% at 10 years. Others have also found the 2-year landmark to be a better predictor of outcome than 6 months or 1 year.3,6,7 Elwes et al.6 found that remission 1 year after TL was associated with a 90% chance of subsequent seizure freedom, a figure that rose to 94% after two consecutive SF years.6 In the same series, no patients who were SF after 2 years had a poor outcome at the time of last follow-up (median, 5 years). Sperling et al.3 reported the time to recurrence after TL in patients with a minimum follow-up of 5 years. In that series,3 seizures recurred within 6 months of surgery in 55% of patients, 1 year in 70% of patients, and 2 years in 93% of patients. By the fifth postoperative year, recurrent seizures were observed in 18% of patients who were SF during the first postoperative year and in only 6% of those who were SF for the first 2 years.

In the current series, the majority of recurrences (86%) took place within 2 years of surgery. Recurrences after 2 years occurred in six patients, only two of whom failed to achieve a 2-year remission subsequently during follow-up. Relapse rates within 10 years of TL were found to be higher for patients with developmental lesions and mesial temporal sclerosis (MTS; 25% and 14% respectively), compared with tumors and normal tissue (1%) and vascular lesions (10%).8 In another series, patients with MTS appeared to be at a slightly increased risk of recurrent seizures compared with those with foreign tissue lesions and normal pathology.9 In that series,9 all recurrences in patients with MTS occurred after 30 months. Explanations for these findings include the presence of dual pathology, bilateral TLE, and incomplete resection of the epileptogenic zone, which was the case in 10 of 11 patients who had recurrent seizures 10 years after TL.10 In a series of temporal and extratemporal resections,11 seizures recurred in the first postoperative year in 86% of patients. Multiple recurrences were observed in 80% of patients, and 40% became medically intractable.11 The interval to first recurrence was not predictive of subsequent course; however, no patients recurring more than 1 year from surgery became intractable. Our data support a previous finding that seizures recurring beyond the first few years after surgery tend to be controlled readily with medical therapy.10 The small number of late recurrences in our study precludes a comparison of outcome by etiology.

Our study has two major limitations. Before the mid 1980s at our institution, the mesial temporal structures were resected in a piecemeal fashion. This often rendered the pathologic specimen unsuitable for analysis. The absence of pathologic diagnoses in many of our patients precludes a direct comparison with contemporary series of patients with MTS—the most common pathologic substrate of patients with medically refractory TLE.12 Nevertheless, we suspect that majority of our patients had mesial temporal lobe epilepsy (MTLE) due to MTS based on the high incidence of febrile seizures, the types of auras and seizure symptomatology, and the distribution of interictal abnormalities.13

The other major limitation of this study is the lack of video-EEG monitoring, structural and functional neuroimaging, and neuropsychological assessments in all patients. Although all of our subjects had interictal EEG recordings, less than one-half had seizures recorded, and few had neuropsychological evaluations or intracarotid Amytal tests. The addition of MRI, PET, SPECT, and MRS to the presurgical evaluation came long after most of our patients were considered for surgery. It is now known that the likelihood of a favorable seizure outcome is increased in the presence of a lesion or unilateral hippocampal atrophy on MRI, concordance of EEG and MRI abnormalities, completeness of resection of the epileptogenic zone, and unilateral hypometabolism on [18F]fluorodeoxyglucose (FDG) PET.9,14-16 For these reasons, our data cannot be compared directly with contemporary series of patients with MTLE. Nevertheless, we believe this series is a valuable one, demonstrating the long-term benefit of TL in patients with refractory seizures arising from the temporal lobe.

Acknowledgments

Acknowledgment

The authors thank Ruth Ellen Weldon for assistance with data collection.

  • Received February 16, 1999.
  • Accepted September 18, 1999.

References

  1. ↵
    Penfield W, Flanigin W. Surgery of temporal lobe seizures. Arch Neurol Psychiatry 1950;64:491–500.
    OpenUrlCrossRef
  2. ↵
    Engel J Jr, Van Ness P, Rasmussen TB, Ojemann L. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies. 2nd ed. New York:Raven Press, 1993:609–621.
  3. ↵
    Sperling MR, O’Connor MJ, Saykin AJ, Plummer C. Temporal lobectomy for refractory epilepsy. JAMA 1996;276:470–475.
    OpenUrlCrossRefPubMed
  4. ↵
    Eliashiv SD, Dewar S, Wainwright I, Engel J Jr, Fried I. Long-term follow-up after temporal lobe resection for lesions associated with chronic seizures. Neurology 1997;48:621–626.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Walczak TS, Radtke RA, McNamara JO, et al. Anterior temporal lobectomy for complex partial seizures: evaluation, results, and long-term follow-up in 100 patients. Neurology 1990;40:413–418.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Elwes RDC, Dunn G, Binnie CD, Polkey CE. Outcome following resective surgery for temporal lobe epilepsy: a prospective follow up study of 102 consecutive patients. J Neurol Neurosurg Psychiatry 1991;54:949–952.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Rougier A, Dartigues J, Commenges D, Claverie B, Loisseau P, Cohadon F. A longitudinal assessment of seizure outcome and overall benefit from 100 cordectomies for epilepsy. J Neurol Neurosurg Psychiatry 1992;55:762–767.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Spencer SS. Long-term outcome after epilepsy surgery. Epilepsia 1996;7:807–813.
    OpenUrl
  9. ↵
    Berkovic SF, McIntosh AM, Kalnins RM, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology 1995;45:1358–1363.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Paillas JE, Gastaut H, Sedan R, Bureau M. Long-term results of conventional surgical treatment for epilepsy: delayed recurrence after a period of 10 years. Surg Neurol 1983;20:189–193.
    OpenUrlCrossRefPubMed
  11. ↵
    Wingkun EC, Awad IA, Lühders H, Awad CA. Natural history of recurrent seizures after resective surgery for epilepsy. Epilepsia 1991;32:851–856.
    OpenUrlPubMed
  12. ↵
    Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia:Lippincott-Raven, 1997:133–155.
  13. ↵
    French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy. I: Results of history and physical examination. Ann Neurol 1993;34:774–780.
    OpenUrlCrossRefPubMed
  14. ↵
    Awad IA, Katz A, Hahn JF, Kong Ahl J, Lühders H. Extent of resection in temporal lobectomy for epilepsy. I. Interobserver analysis and correlation with seizure outcome. Epilepsia 1989;30:756–762.
    OpenUrlPubMed
  15. Jack CR Jr, Sharbrough FW, Cascino GD, Hirschorn KA, O’Brien PC, March R. Magnetic resonance imaging-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992;31:138–146.
    OpenUrlCrossRefPubMed
  16. ↵
    Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992;32:789–794.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    New-onset temporal lobe epilepsy in children
    Lesion on MRI predicts poor seizure outcome
    C. G. Spooner, S. F. Berkovic, L. A. Mitchell et al.
    Neurology, November 02, 2006
  • Articles
    A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy
    A. M. Kanner, R. Byrne, A. Chicharro et al.
    Neurology, March 02, 2009
  • Articles
    Predictors of outcome in pediatric epilepsy surgery
    J.M. Paolicchi, P. Jayakar, P. Dean et al.
    Neurology, February 08, 2000
  • Article
    Presurgical thalamic “hubness” predicts surgical outcome in temporal lobe epilepsy
    Xiaosong He, Gaelle E. Doucet, Dorian Pustina et al.
    Neurology, May 17, 2017
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise